The study by Pfeifer et al. found that over 55% of GCB-DLBCL patients had deregulation of the pathway involving PI3K/AKT as a result of PTEN loss, compared to just 14% of non-GCB-DLBCL cases. Here, AKT1 is linked to diffuse large B-cell lymphoma.